Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS)
Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS)
The initial hypothesis is that branched-chain aminoacids (BCAA) administration could be
 beneficial to patients suffering from sleep apnea syndrome (SAS), the aim of the present work
 is to verify this hypothesis.

 The literature data demonstrate that a BCAA complementation improves the physical
 performances, protects lean mass and increases VO2 max during training.

 We demonstrated earlier that this complementation can cure at less partly the hypoxemia of
 chronic obstructive pulmonary patients by a stimulation of respiratory centres.
Inclusion Criteria:

 -  Adult with healthy mind, who has attained his majority, and affiliated to Social
 Security.

 -  Patient suffering from SAS confirmed by polysomnography (PSG).

 -  Written informed consent form signed.

 Exclusion Criteria:

 -  Patients receiving neuroleptics or benzodiazepines and affiliated drugs will not be
 included in the study.

 -  Patients suffering for severe SAS : those who have a number of IAH higher than 30 in a
 validated sleep hour, will be excluded for security reasons.

 -  Pregnant women, nursing mothers or women susceptible to procreate without efficient
 contraception.

 -  Patient presenting hypersensitivity to understudying products and their excipients.